• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Cardiovascular Medical Device Market

    ID: MRFR/MED/28667-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    Cardiovascular Medical Device Market Research Report By Device Type (Cardiac Implants, Diagnostic Imaging Equipment, Extracorporeal Life Support (ECLS), Surgical Tools and Equipment), By Indication (Coronary Artery Disease, Heart Failure, Arrhythmias, Valvular Heart Disease), By Technology (Bioresorbable Devices, Robotic-Assisted Surgery, Wearable Monitoring Systems, 3D Printing), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Rehabilitation Facilities, Home Healthcare Settings), By Reimbursement Model (Fee-for-Service, Bundled...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cardiovascular Medical Device Market Research Report—Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Cardiovascular Medical Device Market Summary

    The Global Cardiovascular Medical Device Market is projected to grow from 50.7 USD Billion in 2024 to 77.5 USD Billion by 2035.

    Key Market Trends & Highlights

    Cardiovascular Medical Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.93 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 77.5 USD Billion, reflecting a robust growth trajectory.
    • In 2024, the market is valued at 50.7 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of advanced cardiovascular technologies due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 50.7 (USD Billion)
    2035 Market Size 77.5 (USD Billion)
    CAGR (2025-2035) 3.93%

    Major Players

    Siemens Healthineers, Johnson & Johnson, Medtronic, Terumo Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, Stryker Corporation, GE Healthcare, LivaNova PLC, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Asahi Intecc Co., Ltd., Abbott Laboratories, Jude Medical

    Cardiovascular Medical Device Market Trends

    The Cardiovascular Medical Device Market is driven by the rising prevalence of cardiovascular diseases, increasing demand for advanced and minimally invasive treatments, technological advancements, and government initiatives to promote cardiovascular health.

    Opportunities for growth lie in the adoption of personalized and remote monitoring technologies, the expansion of markets in developing countries, and the integration of artificial intelligence and machine learning in cardiovascular care.

    Recent trends include the shift towards value-based healthcare, the focus on preventive care, and the growing adoption of digital health solutions.

    The ongoing advancements in cardiovascular medical devices are poised to enhance patient outcomes and expand access to innovative therapies, reflecting a commitment to improving cardiovascular health globally.

    U.S. Food and Drug Administration (FDA)

    Cardiovascular Medical Device Market Drivers

    Market Growth Projections

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Cardiovascular Medical Device Market Industry. As lifestyle-related factors such as obesity, sedentary behavior, and unhealthy diets continue to rise, the demand for cardiovascular medical devices is expected to grow. In 2024, the market is projected to reach 50.7 USD Billion, reflecting the urgent need for innovative solutions to manage and treat heart conditions. This trend is likely to persist, with projections indicating that by 2035, the market could expand to 77.5 USD Billion, highlighting the critical role of medical devices in addressing this health crisis.

    Regulatory Support and Reimbursement Policies

    Supportive regulatory frameworks and favorable reimbursement policies are crucial drivers of the Global Cardiovascular Medical Device Market Industry. Governments and health authorities are increasingly recognizing the importance of cardiovascular health, leading to streamlined approval processes for new devices. Additionally, reimbursement policies that cover innovative treatments encourage healthcare providers to adopt advanced technologies. This regulatory environment not only fosters innovation but also enhances market confidence, as manufacturers are more likely to invest in research and development. The alignment of regulatory support with market needs is expected to facilitate the introduction of cutting-edge cardiovascular devices, thereby stimulating market growth.

    Technological Advancements in Medical Devices

    Technological innovations are transforming the landscape of the Global Cardiovascular Medical Device Market Industry. Advancements in imaging technologies, minimally invasive procedures, and wearable devices are enhancing diagnostic and therapeutic capabilities. For instance, the integration of artificial intelligence in imaging devices allows for more accurate assessments of cardiovascular health. These innovations not only improve patient outcomes but also drive market growth as healthcare providers seek to adopt the latest technologies. The ongoing research and development in this sector suggest a robust future for cardiovascular devices, potentially leading to a compound annual growth rate of 3.93% from 2025 to 2035.

    Aging Population and Increased Healthcare Expenditure

    The demographic shift towards an aging population is a significant factor influencing the Global Cardiovascular Medical Device Market Industry. Older adults are more susceptible to cardiovascular diseases, necessitating advanced medical interventions. As healthcare expenditure increases globally, particularly in developed nations, there is a growing investment in cardiovascular medical devices. This trend is expected to bolster market growth, as healthcare systems prioritize the management of chronic diseases associated with aging. The financial commitment to improving cardiovascular health is likely to enhance the accessibility and availability of innovative medical devices, further driving market expansion.

    Growing Awareness and Preventive Healthcare Initiatives

    Rising awareness about cardiovascular health and preventive healthcare initiatives are pivotal in shaping the Global Cardiovascular Medical Device Market Industry. Educational campaigns aimed at promoting heart health are encouraging individuals to seek regular check-ups and adopt healthier lifestyles. This proactive approach to health management is driving demand for cardiovascular devices, as early detection and intervention become increasingly prioritized. The emphasis on preventive care not only enhances patient outcomes but also contributes to the overall growth of the market. As awareness continues to expand, the market is likely to witness a surge in the adoption of innovative cardiovascular solutions.

    Market Segment Insights

    Cardiovascular Medical Device Market Device Type Insights

    The Cardiovascular Medical Device Market segmentation by Device Type comprises Cardiac Implants, Diagnostic Imaging Equipment, Extracorporeal Life Support (ECLS), and Surgical Tools and Equipment. Cardiac Implants held the largest market share in 2023, with a significant contribution to the overall revenue.

    The rising prevalence of cardiovascular diseases, technological advancements, and increasing adoption of minimally invasive procedures drive the segment's growth. Pacemakers, defibrillators, and heart valves are the primary products in this category.

    Diagnostic Imaging Equipment is another major segment, witnessing steady growth due to the increasing demand for accurate and non-invasive diagnostic techniques. Advanced imaging modalities like Echocardiography, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) are gaining traction, aiding in the early detection and diagnosis of cardiovascular conditions.

    Extracorporeal Life Support (ECLS) plays a crucial role in managing patients with severe heart and lung failure. The segment is projected to expand as the number of critical care cases rises and technological advancements enhance the effectiveness of ECLS devices.

    Surgical Tools and Equipment include a wide range of instruments used in cardiovascular surgeries. The growing number of cardiac procedures, coupled with the introduction of innovative surgical techniques, is propelling the segment's growth. Specialized tools, such as robotic-assisted surgery systems and laser devices, are gaining popularity due to their precision and reduced invasiveness.

    Cardiovascular Medical Device Market Indication Insights

    The cardiovascular medical device market is segmented by indication into coronary artery disease, heart failure, arrhythmias, and valvular heart disease. Coronary artery disease is the leading cause of death worldwide, and it is estimated that the coronary artery disease market will reach $20.1 billion by 2024.

    Heart failure is the leading cause of hospitalization in the United States, and the heart failure market is expected to reach $12.5 billion by 2024. Arrhythmias are disorders of the heart's electrical system, and the arrhythmias market is expected to reach $7.8 billion by 2024.

    Valvular heart disease is a condition that affects the heart's valves, and the valvular heart disease market is expected to reach $6.3 billion by 2024.

    Cardiovascular Medical Device Market Technology Insights

    The Cardiovascular Medical Device Market segmentation by Technology can be divided into Bioresorbable Devices, Robotic-Assisted Surgery, Wearable Monitoring Systems, and 3D Printing. The Robotic-Assisted Surgery segment is anticipated to experience considerable growth over the forecast period, primarily attributed to the rising adoption of minimally invasive surgical procedures.

    The Wearable Monitoring Systems segment is also projected to witness significant growth due to the increasing prevalence of chronic cardiovascular diseases and the growing demand for remote patient monitoring solutions.

    Moreover, the Bioresorbable Devices segment is expected to gain traction as these devices offer several advantages over traditional implants, such as improved biocompatibility and reduced risk of infection.

    Cardiovascular Medical Device Market End User Insights

    The end-user segment of the Cardiovascular Medical Device Market is diverse, comprising various healthcare settings where cardiovascular medical devices are utilized to diagnose, treat, and monitor cardiovascular conditions.

    Hospitals continue to dominate the market, accounting for a significant share of the Cardiovascular Medical Device Market revenue due to the comprehensive range of cardiovascular services they offer, including advanced diagnostic imaging, surgical interventions, and post-operative care.

    Ambulatory surgical centers have gained prominence in recent years, offering specialized cardiovascular procedures in a cost-effective outpatient setting.

    Cardiac rehabilitation facilities play a crucial role in post-operative care and long-term management of cardiovascular patients, contributing to the market growth. Home healthcare settings are expanding their scope, providing remote monitoring and support for patients with chronic cardiovascular conditions, leading to increased demand for portable and user-friendly devices.

    Cardiovascular Medical Device Market Reimbursement Model Insights

    The Cardiovascular Medical Device Market is segmented based on the Reimbursement Model into Fee-for-Service, Bundled Payments, Value-Based Purchasing, and Subscription Models. Fee-for-Service is the traditional reimbursement model, where providers are paid for each service, they provide.

    Bundled Payments are a type of value-based reimbursement where providers are paid a fixed amount for a bundle of services related to a specific episode of care. Value-based purchasing is another type of value-based reimbursement, where providers are paid based on the quality and outcomes of the care they provide.

    Subscription Models are a newer type of reimbursement model, where patients pay a monthly or annual fee for access to a range of services. Value-Based Purchasing is expected to be the fastest-growing segment, with a CAGR of 4.5% over the forecast period.

    This growth is due to the increasing focus on value-based healthcare and the adoption of value-based payment models by governments and private payers.

    Get more detailed insights about Cardiovascular Medical Device Market Research Report—Forecast till 2032

    Regional Insights

    The regional segmentation of the Cardiovascular Medical Device Market offers valuable insights into the geographical distribution of market growth. North America holds a significant market share, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and technological advancements.

    Europe follows closely, with a well-established healthcare system and a growing elderly population. APAC is expected to witness substantial growth in the coming years due to rising disposable incomes, increasing healthcare expenditure, and a growing awareness of cardiovascular health.

    South America and MEA are emerging markets with significant growth potential, owing to government initiatives to improve healthcare access and rising private sector investments.

    Cardiovascular Medical Devices Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in the Cardiovascular Medical Device Market are continuously involved in strategic collaborations, product launches, and acquisitions to maintain their competitive edge. They are focusing on developing innovative and technologically advanced products to meet the evolving needs of patients and healthcare providers.

    The market is characterized by a high degree of competition, with leading Cardiovascular Medical Device Market players such as Abbott Laboratories, Medtronic, Boston Scientific Corporation, Johnson & Johnson, and Siemens Healthineers holding a significant share.

    Boston Scientific Corporation, a leading Cardiovascular Medical Device Market player, offers a wide range of products, including stents, catheters, and pacemakers. The company has a strong focus on research and development, which has led to the launch of several innovative products in recent years.

    Boston Scientific Corporation's commitment to quality and patient care has earned it a reputation for excellence in the industry.

    Another major competitor in the Cardiovascular Medical Device Market is Siemens Healthineers. The company is known for its advanced imaging technologies, such as MRI and CT scanners. Siemens Healthineers also offers a range of cardiovascular medical devices, including stents, catheters, and pacemakers.

    The company's strong brand recognition and presence have contributed to its success in the market. Siemens Healthineers is actively involved in strategic partnerships and acquisitions to expand its product portfolio and geographical reach.

    Key Companies in the Cardiovascular Medical Device Market market include

    Industry Developments

    • Q2 2024: Boston Scientific to acquire Silk Road Medical for $1.2 billion Boston Scientific announced a definitive agreement to acquire Silk Road Medical, a developer of devices for stroke prevention in patients with carotid artery disease, for $1.2 billion in cash. The deal expands Boston Scientific’s portfolio in the vascular intervention space.
    • Q2 2024: Medtronic wins FDA approval for Symplicity Spyral renal denervation system Medtronic received FDA approval for its Symplicity Spyral renal denervation system, a device designed to treat hypertension, marking a significant regulatory milestone for the company’s cardiovascular business.
    • Q1 2024: Abbott launches TriClip transcatheter tricuspid valve repair system in Europe Abbott announced the commercial launch of its TriClip transcatheter tricuspid valve repair system in select European markets following CE Mark approval, expanding its structural heart device offerings.
    • Q2 2024: Shockwave Medical completes acquisition of Neovasc Inc. Shockwave Medical finalized its acquisition of Neovasc Inc., a company specializing in devices for refractory angina, strengthening Shockwave’s position in the cardiovascular device sector.
    • Q1 2024: FDA approves Edwards Lifesciences’ EVOQUE tricuspid valve replacement system Edwards Lifesciences received FDA approval for its EVOQUE tricuspid valve replacement system, the first transcatheter therapy for tricuspid regurgitation to be approved in the United States.
    • Q2 2024: CardioSignal raises $15M Series B to expand AI-powered heart disease detection platform CardioSignal, a health tech startup focused on AI-driven heart disease detection, secured $15 million in Series B funding to accelerate product development and expand its global reach.
    • Q1 2024: Biotronik announces partnership with Mayo Clinic for remote cardiac monitoring Biotronik entered into a strategic partnership with Mayo Clinic to advance remote cardiac monitoring solutions, aiming to improve patient outcomes through enhanced data analytics and device connectivity.
    • Q2 2024: Philips launches new Azurion image-guided therapy platform for cardiovascular procedures Philips introduced its latest Azurion platform, designed to support complex cardiovascular interventions with advanced imaging and workflow capabilities, targeting hospitals and specialty clinics.
    • Q1 2024: Terumo opens new manufacturing facility for cardiovascular devices in North Carolina Terumo announced the opening of a new manufacturing facility in North Carolina dedicated to producing advanced cardiovascular devices, supporting increased demand and expanding its U.S. footprint.
    • Q2 2024: Shockwave Medical completes $200M public offering Shockwave Medical completed a $200 million public offering to fund further development and commercialization of its intravascular lithotripsy technology for cardiovascular applications.
    • Q1 2024: Boston Scientific announces partnership with HeartFlow to advance coronary artery disease diagnostics Boston Scientific formed a partnership with HeartFlow to integrate HeartFlow’s AI-powered coronary artery disease diagnostic platform with Boston Scientific’s interventional cardiology solutions.
    • Q2 2024: Abbott appoints new head of global cardiovascular device division Abbott named Dr. Lisa Chen as the new head of its global cardiovascular device division, signaling a strategic focus on innovation and international expansion.

    Future Outlook

    Cardiovascular Medical Device Market Future Outlook

    The Global Cardiovascular Medical Device Market is projected to grow at a 3.93% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop innovative minimally invasive devices to enhance patient recovery times.
    • Leverage AI and machine learning for predictive analytics in cardiovascular care.
    • Expand telehealth solutions for remote monitoring of cardiovascular patients.

    By 2035, the market is expected to demonstrate robust growth, reflecting advancements and increased demand in cardiovascular healthcare.

    Market Segmentation

    Cardiovascular Medical Device Market End User Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Rehabilitation Facilities
    • Home Healthcare Settings

    Cardiovascular Medical Devices Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Cardiovascular Medical Device Market Indication Outlook

    • Coronary Artery Disease
    • Heart Failure
    • Arrhythmias
    • Valvular Heart Disease

    Cardiovascular Medical Device Market Technology Outlook

    • Bioresorbable Devices
    • Robotic-Assisted Surgery
    • Wearable Monitoring Systems
    • 3D Printing

    Cardiovascular Medical Device Market Device Type Outlook

    • Cardiac Implants
    • Diagnostic Imaging Equipment
    • Extracorporeal Life Support (ECLS)
    • Surgical Tools and Equipment

    Cardiovascular Medical Device Market Reimbursement Model Outlook

    • Fee-for-Service
    • Bundled Payments
    • Value-Based Purchasing
    • Subscription Models

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024   50.72 (USD Billion)
    Market Size 2025   52.72 (USD Billion)
    Market Size 2034   74.59 (USD Billion)
    Compound Annual Growth Rate (CAGR)    3.93 % (2025 - 2034)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2034
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Siemens Healthineers, Johnson Johnson, Medtronic, Terumo Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, Stryker Corporation, GE Healthcare, LivaNova PLC, Edwards Lifesciences Corporation, Koninklijke Philips N.V., Asahi Intecc Co., Ltd., Abbott Laboratories, St. Jude Medical
    Segments Covered Device Type, Indication, Technology, End User, Reimbursement Model, Regional
    Key Market Opportunities 1 Implantable device 2 Cardiac rhythm management 3 Structural heart disease devices 4 Peripheral vascular interventions 5 Electrophysiology mapping and navigation systems
    Key Market Dynamics Aging population, technological advancements, rising prevalence of cardiovascular diseases, favorable government policies, and increasing healthcare expenditure
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What was the size of the Cardiovascular Medical Device Market in 2023?

    The cardiovascular medical device market was valued at USD 46.96 billion in 2023.

    What is the projected size of the Cardiovascular Medical Device Market in 2034?

    The cardiovascular medical device market is projected to reach USD 66.43 billion by 2034.

    What is the CAGR of the Cardiovascular Medical Device Market?

    The CAGR of the cardiovascular medical device market is estimated to be 3.93% from 2025 to 2034.

    Which region is expected to hold the largest share of the Cardiovascular Medical Device Market?

    North America is expected to hold the largest share of the cardiovascular medical device market in 2034.

    Which application segment is expected to drive the growth of the Cardiovascular Medical Device Market?

    The cardiovascular implants segment is expected to drive the growth of the cardiovascular medical device market.

    Who are the key competitors in the Cardiovascular Medical Device Market?

    Some of the key competitors in the cardiovascular medical device market include Medtronic, Johnson Johnson, Abbott Laboratories, Siemens Healthineers, and GE Healthcare.

    What are the major factors driving the growth of the Cardiovascular Medical Device Market?

    The increasing prevalence of cardiovascular diseases, technological advancements, and rising healthcare expenditure are driving the growth of the cardiovascular medical device market.

    What are the major challenges faced by the Cardiovascular Medical Device Market?

    The high cost of cardiovascular medical devices and stringent regulatory requirements are some of the major challenges faced by the cardiovascular medical device market.

    What are the key trends in the Cardiovascular Medical Device Market?

    The key trends in the cardiovascular medical device market include the increasing adoption of minimally invasive procedures, the development of personalized medical devices, and the growing use of artificial intelligence in cardiovascular care.

    What are the growth opportunities for the Cardiovascular Medical Device Market?

    The growth opportunities for the cardiovascular medical device market include the expansion into emerging markets, the development of new and innovative technologies, and the increasing focus on preventive care.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials